[Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]
- PMID: 17048017
- DOI: 10.1007/s00108-006-1720-x
[Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study]
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
